Loading...

Ranganath Veena

TitleHealth Sciences Assistant Clinical Professor
InstitutionUniversity of California Los Angeles
DepartmentMedicine
AddressPeter Morton Medical Building
200 UCLA Medical Plaza Suite 365-B
Los Angeles CA 90095
Phone310-825-0419
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Biomarkers for Early Therapeutic Response in Older RA Patients
    NIH/NIAMS K23AR057818Jul 12, 2010 - Jun 30, 2015
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Kaeley GS, MacCarter DK, Pangan AL, Wang X, Kalabic J, Ranganath VK. Clinical Responses and Synovial Vascularity in Obese Rheumatoid Arthritis Patients Treated with Adalimumab and Methotrexate. J Rheumatol. 2018 Sep 01. PMID: 30173153.
      View in: PubMed
    2. Kaeley GS, Ranganath VK. Chasing the Ghost of Imaging Remission in Rheumatoid Arthritis. J Rheumatol. 2018 Jul; 45(7):881-883. PMID: 29961675.
      View in: PubMed
    3. Ranganath VK, Duffy EL, Garg VK, Woodworth T, Taylor M, Paulus HE, Altman RD, Elashoff DA. Obesity Impacts Swelling of Ankle and Foot Joints in Early Rheumatoid Arthritis Patients. J Clin Rheumatol. 2018 Apr 16. PMID: 29683839.
      View in: PubMed
    4. Suliman YA, Kafaja S, Fitzgerald J, Wortsman X, Grotts J, Matucci-Cerrinic M, Ranganath VK, Furst DE. Ultrasound characterization of cutaneous ulcers in systemic sclerosis. Clin Rheumatol. 2018 Jun; 37(6):1555-1561. PMID: 29525847.
      View in: PubMed
    5. Woodworth TG, Morgacheva O, Pimienta OL, Troum OM, Ranganath VK, Furst DE. Examining the validity of the rheumatoid arthritis magnetic resonance imaging score according to the OMERACT filter-a systematic literature review. Rheumatology (Oxford). 2017 07 01; 56(7):1177-1188. PMID: 28398508.
      View in: PubMed
    6. Bauer EM, Ben-Artzi A, Duffy EL, Elashoff DA, Vangala SS, Fitzgerald J, Ranganath VK. Joint-specific assessment of swelling and power Doppler in obese rheumatoid arthritis patients. BMC Musculoskelet Disord. 2017 03 04; 18(1):99. PMID: 28259162.
      View in: PubMed
    7. Peterfy C, Strand V, Tian L, Østergaard M, Lu Y, DiCarlo J, Countryman P, Deodhar A, Landewé R, Ranganath VK, Troum O, Conaghan PG. Short-term changes on MRI predict long-term changes on radiography in rheumatoid arthritis: an analysis by an OMERACT Task Force of pooled data from four randomised controlled trials. Ann Rheum Dis. 2017 Jun; 76(6):992-997. PMID: 27974302.
      View in: PubMed
    8. Ranganath VK, Strand V. Importance of 'meeting of the minds': patient-reported outcomes and MRI. Ann Rheum Dis. 2017 Mar; 76(3):473-475. PMID: 27689734.
      View in: PubMed
    9. Ranganath VK, Ben-Artzi A, Duffy E, Brook J, Taylor M, Choi S, Paulus H, Elashoff DA. Elevated baseline power Doppler discriminates an RA subgroup highly responsive to therapy. Rheumatology (Oxford). 2015 Dec; 54(12):2285-6. PMID: 26316582; PMCID: PMC4938871 [Available on 12/01/16].
    10. Ranganath VK, Motamedi K, Haavardsholm EA, Maranian P, Elashoff D, McQueen F, Duffy EL, Bathon JM, Curtis JR, Chen W, Moreland L, Louie J, Amjadi S, O'Dell J, Cofield SS, St Clair EW, Bridges SL, Paulus HE. Comprehensive appraisal of magnetic resonance imaging findings in sustained rheumatoid arthritis remission: a substudy. Arthritis Care Res (Hoboken). 2015 Jul; 67(7):929-39. PMID: 25581612; PMCID: PMC4482777.
    11. Troum OM, Pimienta OL, Schmidt WA, Ostergaard M, D'Agostino MA, Gaylis N, Arnold W, Ben-Artzi A, Ranganath V, Seraphine JL, Peterfy C. Proceedings from the 7th Annual International Society for Musculoskeletal Imaging in Rheumatology (ISEMIR) conference. Semin Arthritis Rheum. 2015 Aug; 45(1):115-21. PMID: 25908178.
      View in: PubMed
    12. Martin WJ, Shim M, Paulus HE, Chaudhari S, Feng J, Elashoff D, Hahn TJ, Ranganath VK. Older age at rheumatoid arthritis onset and comorbidities correlate with less Health Assessment Questionnaire-Disability Index and Clinical Disease Activity Index response to etanercept in the RADIUS 2 registry. J Clin Rheumatol. 2014 Sep; 20(6):301-5. PMID: 25160011; PMCID: PMC4560341.
    13. Charles-Schoeman C, Lee YY, Shahbazian A, Gorn AH, Fitzgerald J, Ranganath VK, Taylor M, Ragavendra N, McMahon M, Elashoff D, Reddy ST. Association of paraoxonase 1 gene polymorphism and enzyme activity with carotid plaque in rheumatoid arthritis. Arthritis Rheum. 2013 Nov; 65(11):2765-72. PMID: 23917967; PMCID: PMC4410876.
    14. O'Dell JR, Curtis JR, Mikuls TR, Cofield SS, Bridges SL, Ranganath VK, Moreland LW. Validation of the methotrexate-first strategy in patients with early, poor-prognosis rheumatoid arthritis: results from a two-year randomized, double-blind trial. Arthritis Rheum. 2013 Aug; 65(8):1985-94. PMID: 23686414; PMCID: PMC4768726.
    15. Ranganath VK, Maranian P, Elashoff DA, Woodworth T, Khanna D, Hahn T, Sarkisian C, Kremer JM, Furst DE, Paulus HE. Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritis. Rheumatology (Oxford). 2013 Oct; 52(10):1809-17. PMID: 23813577; PMCID: PMC3775293.
    16. Curtis JR, McVie T, Mikuls TR, Reynolds RJ, Navarro-Millán I, O'Dell J, Moreland LW, Bridges SL, Ranganath VK, Cofield SS. Clinical response within 12 weeks as a predictor of future low disease activity in patients with early RA: results from the TEAR Trial. J Rheumatol. 2013 May; 40(5):572-8. PMID: 23588939; PMCID: PMC3694569.
    17. Doyle MK, Rahman MU, Frederick B, Birbara CA, de Vries D, Toedter G, Wu X, Chen D, Ranganath VK, Westerman ME, Furst DE. Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis: results of a phase 1, randomized, open-label trial. Rheumatology (Oxford). 2013 Jul; 52(7):1214-9. PMID: 23418046.
      View in: PubMed
    18. Jawaheer D, Messing S, Reed G, Ranganath VK, Kremer JM, Louie JS, Khanna D, Greenberg JD, Furst DE. Significance of sex in achieving sustained remission in the consortium of rheumatology researchers of North America cohort of rheumatoid arthritis patients. Arthritis Care Res (Hoboken). 2012 Dec; 64(12):1811-8. PMID: 22730408; PMCID: PMC3604992.
    19. McAlindon T, Kissin E, Nazarian L, Ranganath V, Prakash S, Taylor M, Bannuru RR, Srinivasan S, Gogia M, McMahon MA, Grossman J, Kafaja S, FitzGerald J. American College of Rheumatology report on reasonable use of musculoskeletal ultrasonography in rheumatology clinical practice. Arthritis Care Res (Hoboken). 2012 Nov; 64(11):1625-40. PMID: 23111854.
      View in: PubMed
    20. Irwin MR, Olmstead R, Carrillo C, Sadeghi N, Fitzgerald JD, Ranganath VK, Nicassio PM. Sleep loss exacerbates fatigue, depression, and pain in rheumatoid arthritis. Sleep. 2012 Apr 01; 35(4):537-43. PMID: 22467992; PMCID: PMC3296796.
    21. Charles-Schoeman C, Lee YY, Grijalva V, Amjadi S, FitzGerald J, Ranganath VK, Taylor M, McMahon M, Paulus HE, Reddy ST. Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis. Ann Rheum Dis. 2012 Jul; 71(7):1157-62. PMID: 22267330; PMCID: PMC3428121.
    22. Shammas RM, Ranganath VK, Paulus HE. Remission in rheumatoid arthritis. Curr Rheumatol Rep. 2010 Oct; 12(5):355-62. PMID: 20697983; PMCID: PMC2927687.
    23. Grossman JM, Gordon R, Ranganath VK, Deal C, Caplan L, Chen W, Curtis JR, Furst DE, McMahon M, Patkar NM, Volkmann E, Saag KG. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken). 2010 Nov; 62(11):1515-26. PMID: 20662044.
      View in: PubMed
    24. Ranganath VK. Through the looking glass: "remission" in rheumatoid arthritis. J Rheumatol. 2010 Jul; 37(7):1371-3. PMID: 20595289.
      View in: PubMed
    25. Weng HH, Ranganath VK, Khanna D, Oh M, Furst DE, Park GS, Elashoff DA, Sharp JT, Gold RH, Peter JB, Paulus HE. Equivalent responses to disease-modifying antirheumatic drugs initiated at any time during the first 15 months after symptom onset in patients with seropositive rheumatoid arthritis. J Rheumatol. 2010 Mar; 37(3):550-7. PMID: 20110517; PMCID: PMC3413376.
    26. Wong M, Ranganath VK, Clements PJ. Antineutrophil cytoplasmic antibody-positive digital necrosis in a patient with limited systemic sclerosis. J Rheumatol. 2010 Jan; 37(1):214-5. PMID: 20040651; PMCID: PMC3038343.
    27. Amjadi SS, Maranian PM, Paulus HE, Kaplan RM, Ranganath VK, Furst DE, Khanna PP, Khanna D. Validating and assessing the sensitivity of the Health Assessment Questionnaire-Disability Index-derived Short Form-6D in patients with early aggressive rheumatoid arthritis. J Rheumatol. 2009 Jun; 36(6):1150-7. PMID: 19369459; PMCID: PMC2880525.
    28. Ranganath VK, Paulus HE, Onofrei A, Khanna D, Reed G, Elashoff DA, Kremer JM, Furst DE. Functional improvement after patients with rheumatoid arthritis start a new disease modifying antirheumatic drug (DMARD) associated with frequent changes in DMARD: the CORRONA database. J Rheumatol. 2008 Oct; 35(10):1966-71. PMID: 18785317; PMCID: PMC2753191.
    29. MacLean C, Newberry S, Maglione M, McMahon M, Ranganath V, Suttorp M, Mojica W, Timmer M, Alexander A, McNamara M, Desai SB, Zhou A, Chen S, Carter J, Tringale C, Valentine D, Johnsen B, Grossman J. Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med. 2008 Feb 05; 148(3):197-213. PMID: 18087050.
      View in: PubMed
    30. Ranganath VK, Yoon J, Khanna D, Park GS, Furst DE, Elashoff DA, Jawaheer D, Sharp JT, Gold RH, Keystone EC, Paulus HE. Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort. Ann Rheum Dis. 2007 Dec; 66(12):1633-40. PMID: 17472996; PMCID: PMC2095300.
    31. Khanna D, Oh M, Furst DE, Ranganath V, Gold RH, Sharp JT, Park GS, Keystone EC, Paulus HE. Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort. Arthritis Rheum. 2007 Apr 15; 57(3):440-7. PMID: 17394230.
      View in: PubMed
    32. Ranganath VK, Furst DE. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient. Rheum Dis Clin North Am. 2007 Feb; 33(1):197-217. PMID: 17367700.
      View in: PubMed
    33. Ranganath VK, Khanna D, Paulus HE. ACR remission criteria and response criteria. Clin Exp Rheumatol. 2006 Nov-Dec; 24(6 Suppl 43):S-14-21. PMID: 17083757.
      View in: PubMed
    34. Ranganath VK, Furst DE. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient. Clin Geriatr Med. 2005 Aug; 21(3):649-69, viii. PMID: 15911212.
      View in: PubMed
    35. Khanna D, Ranganath VK, Fitzgerald J, Park GS, Altman RD, Elashoff D, Gold RH, Sharp JT, Furst DE, Paulus HE. Increased radiographic damage scores at the onset of seropositive rheumatoid arthritis in older patients are associated with osteoarthritis of the hands, but not with more rapid progression of damage. Arthritis Rheum. 2005 Aug; 52(8):2284-92. PMID: 16052588.
      View in: PubMed
    36. Ranganath VK, Elashoff DA, Khanna D, Park G, Peter JB, Paulus HE. Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients. J Rheumatol. 2005 Jun; 32(6):1040-2. PMID: 15940764.
      View in: PubMed